| PID_in_paper | age(yr) | gender | race/ethnicity | infection_duration | pre_ART_duration | ART | ART_duration | pre_suppression_duration | suppression_duration | proviral_DNA_copies_at_sampling | viral_RNA_copies_at_sampling | suppression_status | CD4_at_sampling | sample_comment |
|---|
| ACH2 | | | | | | | | | | | | | | ACH2 cell-line validation control; not a study participant; NT5C3A integrant. |
| C-02 | 62(yr) | M | AA | | | TDF/FTC/EFV | 18(yr) | | | 373 | | | 1022(cells/ul) | Nadir CD4=286; HIV DNA unit=copies/1e6 PBMC; NSV episodes reported. |
| C-03 | 43(yr) | M | C | | | DRV/r/ETV/DTG | 9(yr) | | | 2505 | | | 416(cells/ul) | Nadir CD4=10; HIV DNA unit=copies/1e6 PBMC; NSV episodes reported. |
| F-07 | 59(yr) | M | AA | | | ABC/3TC/EFV | 19(yr) | | | 1603 | | | 1023(cells/ul) | Nadir CD4=314; HIV DNA unit=copies/1e6 PBMC; NSV episodes reported. |
| K-01 | 55(yr) | F | AA | | | TDF/FTC/DRV/r | 2(yr) | | | 1383 | | | 533(cells/ul) | Nadir CD4=133; HIV DNA unit=copies/1e6 PBMC; NSV episodes reported. |
| R-09 | 73(yr) | M | C | | | TDF/FTC/EFV | 10(yr) | | | 1533 | | | 380(cells/ul) | Nadir CD4=105; HIV DNA unit=copies/1e6 PBMC; NSV episodes reported. |